Hedge Fund and Insider Trading News: Elliot Management, Brevan Howard, Acorda Therapeutics Inc (ACOR), Cognizant Technology Solutions Corp (CTSH), and More

Acorda Therapeutics Inc (NASDAQ:ACOR) Insider Sells $854,980.00 in Stock (TrueBlueTribune)
Acorda Therapeutics Inc (NASDAQ:ACOR) insider David Lawrence sold 31,000 shares of the company’s stock in a transaction on Friday, January 19th. The shares were sold at an average price of $27.58, for a total value of $854,980.00. Following the completion of the transaction, the insider now directly owns 5,275 shares in the company, valued at approximately $145,484.50. The sale was disclosed in a filing with the SEC.

Insider Selling: Cognizant Technology Solutions Corp (CTSH) Insider Sells 2,625 Shares of Stock (The Ledger Gazette)
Cognizant Technology Solutions Corp (NASDAQ:CTSH) insider Sumithra Gomatam sold 2,625 shares of the company’s stock in a transaction dated Wednesday, January 17th. The stock was sold at an average price of $76.00, for a total transaction of $199,500.00. Following the transaction, the insider now owns 40,979 shares of the company’s stock, valued at approximately $3,114,404. The transaction was disclosed in a filing with the SEC.

Insider Selling: Keryx Biopharmaceuticals (KERX) COO Sells 9,048 Shares of Stock (Stock News Times)
Keryx Biopharmaceuticals (NASDAQ:KERX) COO Christine A. Carberry sold 9,048 shares of the firm’s stock in a transaction on Thursday, January 18th. The shares were sold at an average price of $4.87, for a total value of $44,063.76. The sale was disclosed in a legal filing with the SEC.

Insider Selling: salesforce.com, inc. (CRM) Chairman Sells $566,850.00 in Stock (TheLincolnianOnline)
Salesforce.com, inc. (NYSE:CRM) Chairman Marc Benioff sold 5,000 shares of the stock in a transaction on Friday, January 26th. The shares were sold at an average price of $113.37, for a total value of $566,850.00. The transaction was disclosed in a legal filing with the SEC.

Insider Selling: Esperion Therapeutics Inc (ESPR) Director Sells $838,076.46 in Stock (The Ledger Gazette)
Esperion Therapeutics Inc (NASDAQ:ESPR) Director Nicole Vitullo sold 11,674 shares of the business’s stock in a transaction that occurred on Thursday, January 25th. The shares were sold at an average price of $71.79, for a total transaction of $838,076.46. Following the completion of the sale, the director now directly owns 3,177 shares in the company, valued at approximately $228,076.83. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.